Ionis Pharmaceuticals
IONS
26.58
-0.64
-2.35%
Ionis Pharmaceuticals
US · IONS
#1749 by market cap
Listed 1970
26.58
-0.64
-2.35%
Periodic snapshot; not a real-time feed.
· 2026-11-20 19:59
Quant vs Street three independent views, side by side
StockVane factor grade
D+
Momentum strategy signal
Strong Sell
Analyst consensus
Buy
Mostly aligned, one view stands apart.
Not investment advice. The factor grade ranks this stock on fundamentals against StockVane's covered universe; the momentum strategy signal is a rules-based backtest, not a recommendation; analyst consensus reflects sell-side coverage. The three use different methods and can reasonably disagree.
✦ Quant Analyst Revision Trend how this is computed
Mixed
1
■ Upgrades■ Downgrades
- 1 upgrade vs 0 downgrades among tracked analyst rating changes.
- Most recent: BMO Capital moved from Hold to Buy on 2026-10-21.
Analyst consensus 19 analysts
Buy
Avg price target 72.39 +172.3%
Price target rangecurrent 26.58
Low41.00
Avg72.39
High100.00
Buy 95%
Hold 5%
Sell 0%
Recent ratings (25)
| Date | Firm | Analyst | Rating | Target |
|---|---|---|---|---|
| 2026-11-11 | Barclays | -- | Buy | 70.00 |
| 2026-11-10 | TD Cowen | -- | Buy | 53.00 |
| 2026-11-10 | CCORF | -- | Buy | 72.00 |
| 2026-11-10 | Wells Fargo | -- | Buy | 80.00 |
| 2026-11-10 | Morgan Stanley | -- | Buy | 75.00 |
| 2026-11-10 | BMO Capital | -- | Buy | 66.00 |
| 2026-11-10 | H.C. Wainwright | -- | Buy | 70.00 |
| 2026-11-10 | Barclays | -- | Buy | 85.00 |
| 2026-11-10 | Oppenheimer | -- | Buy | 70.00 |
| 2026-11-09 | Wells Fargo | -- | Buy | 80.00 |
| 2026-11-09 | UBS | -- | Buy | 81.00 |
| 2026-11-09 | Piper Sandler | -- | Buy | 87.00 |
| 2026-11-09 | BofA Securities | -- | Buy | 63.00 |
| 2026-11-09 | Citi | -- | Buy | 100.00 |
| 2026-11-09 | Goldman Sachs | -- | Hold | 41.00 |
| 2026-11-09 | H.C. Wainwright | -- | Buy | 100.00 |
| 2026-11-09 | RBC Capital | -- | Buy | 60.00 |
| 2026-11-02 | BMO Capital | -- | Buy | 66.00 |
| 2026-10-28 | CCORF | -- | Buy | 85.00 |
| 2026-10-28 | Citi | -- | Buy | 100.00 |
| 2026-10-26 | H.C. Wainwright | -- | Buy | 100.00 |
| 2026-10-21 | Piper Sandler | -- | Buy | 87.00 |
| 2026-10-21 | Morgan Stanley | -- | Buy | 104.00 |
| 2026-10-21 | BMO Capital | -- | Buy | 66.00 |
| 2026-10-21 | Citi | -- | Buy | 100.00 |
Price target trend monthly average, last 3 years
Recent rating changes
| Date | Firm | Change | Target |
|---|---|---|---|
| 2026-10-21 | BMO Capital | Hold → Buy | 66.00 |
Earnings history price reaction on the day
| Period | Report date | Session | Options expected | Actual move |
|---|---|---|---|---|
| 2026/Q3 | 2026-11-09 | -- | ±11.65% | -21.36% (beat) |
| 2026/Q2 | 2026-07-29 | -- | ±8.18% | -2.28% (in line) |
| 2026/Q1 | 2026-04-29 | -- | ±5.49% | +4.25% (in line) |
| 2025/Q4 | 2026-02-25 | -- | ±9.19% | -5.29% (in line) |
| 2025/Q3 | 2025-10-29 | -- | ±10.87% | -2.30% (in line) |
| 2025/Q2 | 2025-07-30 | -- | ±10.68% | +4.56% (in line) |
| 2025/Q1 | 2025-04-30 | -- | ±12.79% | +3.02% (in line) |
| 2024/Q4 | 2025-02-19 | -- | ±9.94% | -0.44% (in line) |
| 2024/Q3 | 2024-11-06 | -- | ±7.14% | +0.62% (in line) |
| 2024/Q2 | 2024-08-01 | -- | ±7.19% | +3.76% (in line) |
| 2024/Q1 | 2024-05-07 | -- | ±6.67% | -3.19% (in line) |
| 2023/Q4 | 2024-02-21 | -- | ±10.24% | -1.85% (in line) |
"Options expected" is the pre-earnings options market's implied move (a straddle-style estimate), shown next to what actually happened.
Quote time 2026-11-20 19:59:29 · For reference only, not investment advice and not tailored to your situation.
Ionis Pharmaceuticals discussion 0 comments